The Role of IL-17 in a Lipopolysaccharide-Induced Rhinitis Model

Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPS-induced non-eosion...

Full description

Saved in:
Bibliographic Details
Published inAllergy, asthma & immunology research Vol. 9; no. 2; pp. 169 - 176
Main Authors Bae, Jun-Sang, Kim, Ji-Hye, Kim, Eun Hee, Mo, Ji-Hun
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 01.03.2017
대한천식알레르기학회
Subjects
Online AccessGet full text
ISSN2092-7355
2092-7363
DOI10.4168/aair.2017.9.2.169

Cover

Abstract Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPS-induced non-eosionophilic rhinitis model. Mice were divided into 4 groups and each group consisted of 10 mice (negative control group, allergic rhinitis model group, 1-μg LPS treatment group, and 10-μg LPS treatment group). BALB/c mice were sensitized with OVA and 1 or 10 μg of LPS, and challenged intranasally with OVA. Multiple parameters of rhinitis were also evaluated to establish the LPS-induced rhinitis model. IL-17 knockout mice were used to check if the LPS-induced rhinitis model were dependent on IL-17. Eosinophil and neutrophil infiltration, and mRNA and protein expression profiles of cytokine in nasal mucosa or spleen cell culture were evaluated using molecular, biochemical, histopathological, and immunohistological methods. In the LPS-induced rhinitis model, neutrophil infiltration increased in the nasal mucosa, and systemic and nasal IL-17 and interferon-gamma (IFN-γ) levels also increased as compared with the OVA-induced allergic rhinitis model. These findings were LPS-dose-dependent. In IL-17 knockout mice, those phenotypes (neutrophil infiltration, IL-17, and IFN-γ) were reversed, showing IL-17 dependency of LPS-induced rhinitis. The expression of vascular endothelial growth factor (VEGF), an important mediator for inflammation and angiogenesis, decreased in IL-17 knockout mice, showing the relationship between IL-17 and VEGF. This study established an LPS-induced rhinitis model dependent on IL-17, characterized by neutrophil infiltration and increased expression of IL-17.
AbstractList Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPS-induced non-eosionophilic rhinitis model.PURPOSELipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPS-induced non-eosionophilic rhinitis model.Mice were divided into 4 groups and each group consisted of 10 mice (negative control group, allergic rhinitis model group, 1-μg LPS treatment group, and 10-μg LPS treatment group). BALB/c mice were sensitized with OVA and 1 or 10 μg of LPS, and challenged intranasally with OVA. Multiple parameters of rhinitis were also evaluated to establish the LPS-induced rhinitis model. IL-17 knockout mice were used to check if the LPS-induced rhinitis model were dependent on IL-17. Eosinophil and neutrophil infiltration, and mRNA and protein expression profiles of cytokine in nasal mucosa or spleen cell culture were evaluated using molecular, biochemical, histopathological, and immunohistological methods.METHODSMice were divided into 4 groups and each group consisted of 10 mice (negative control group, allergic rhinitis model group, 1-μg LPS treatment group, and 10-μg LPS treatment group). BALB/c mice were sensitized with OVA and 1 or 10 μg of LPS, and challenged intranasally with OVA. Multiple parameters of rhinitis were also evaluated to establish the LPS-induced rhinitis model. IL-17 knockout mice were used to check if the LPS-induced rhinitis model were dependent on IL-17. Eosinophil and neutrophil infiltration, and mRNA and protein expression profiles of cytokine in nasal mucosa or spleen cell culture were evaluated using molecular, biochemical, histopathological, and immunohistological methods.In the LPS-induced rhinitis model, neutrophil infiltration increased in the nasal mucosa, and systemic and nasal IL-17 and interferon-gamma (IFN-γ) levels also increased as compared with the OVA-induced allergic rhinitis model. These findings were LPS-dose-dependent. In IL-17 knockout mice, those phenotypes (neutrophil infiltration, IL-17, and IFN-γ) were reversed, showing IL-17 dependency of LPS-induced rhinitis. The expression of vascular endothelial growth factor (VEGF), an important mediator for inflammation and angiogenesis, decreased in IL-17 knockout mice, showing the relationship between IL-17 and VEGF.RESULTSIn the LPS-induced rhinitis model, neutrophil infiltration increased in the nasal mucosa, and systemic and nasal IL-17 and interferon-gamma (IFN-γ) levels also increased as compared with the OVA-induced allergic rhinitis model. These findings were LPS-dose-dependent. In IL-17 knockout mice, those phenotypes (neutrophil infiltration, IL-17, and IFN-γ) were reversed, showing IL-17 dependency of LPS-induced rhinitis. The expression of vascular endothelial growth factor (VEGF), an important mediator for inflammation and angiogenesis, decreased in IL-17 knockout mice, showing the relationship between IL-17 and VEGF.This study established an LPS-induced rhinitis model dependent on IL-17, characterized by neutrophil infiltration and increased expression of IL-17.CONCLUSIONSThis study established an LPS-induced rhinitis model dependent on IL-17, characterized by neutrophil infiltration and increased expression of IL-17.
Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPS-induced non-eosionophilic rhinitis model. Mice were divided into 4 groups and each group consisted of 10 mice (negative control group, allergic rhinitis model group, 1-μg LPS treatment group, and 10-μg LPS treatment group). BALB/c mice were sensitized with OVA and 1 or 10 μg of LPS, and challenged intranasally with OVA. Multiple parameters of rhinitis were also evaluated to establish the LPS-induced rhinitis model. IL-17 knockout mice were used to check if the LPS-induced rhinitis model were dependent on IL-17. Eosinophil and neutrophil infiltration, and mRNA and protein expression profiles of cytokine in nasal mucosa or spleen cell culture were evaluated using molecular, biochemical, histopathological, and immunohistological methods. In the LPS-induced rhinitis model, neutrophil infiltration increased in the nasal mucosa, and systemic and nasal IL-17 and interferon-gamma (IFN-γ) levels also increased as compared with the OVA-induced allergic rhinitis model. These findings were LPS-dose-dependent. In IL-17 knockout mice, those phenotypes (neutrophil infiltration, IL-17, and IFN-γ) were reversed, showing IL-17 dependency of LPS-induced rhinitis. The expression of vascular endothelial growth factor (VEGF), an important mediator for inflammation and angiogenesis, decreased in IL-17 knockout mice, showing the relationship between IL-17 and VEGF. This study established an LPS-induced rhinitis model dependent on IL-17, characterized by neutrophil infiltration and increased expression of IL-17.
Purpose: Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPSinduced non-eosionophilic rhinitis model. Methods: Mice were divided into 4 groups and each group consisted of 10 mice (negative control group, allergic rhinitis model group, 1-μg LPS treatment group, and 10-μg LPS treatment group). BALB/c mice were sensitized with OVA and 1 or 10 μg of LPS, and challenged intranasally with OVA. Multiple parameters of rhinitis were also evaluated to establish the LPS-induced rhinitis model. IL-17 knockout mice were used to check if the LPS-induced rhinitis model were dependent on IL-17. Eosinophil and neutrophil infiltration, and mRNA and protein expression profiles of cytokine in nasal mucosa or spleen cell culture were evaluated using molecular, biochemical, histopathological, and immunohistological methods. Results: In the LPS-induced rhinitis model, neutrophil infiltration increased in the nasal mucosa, and systemic and nasal IL-17 and interferon-gamma (IFN-γ) levels also increased as compared with the OVA-induced allergic rhinitis model. These findings were LPSdose- dependent. In IL-17 knockout mice, those phenotypes (neutrophil infiltration, IL-17, and IFN-γ) were reversed, showing IL-17 dependency of LPS-induced rhinitis. The expression of vascular endothelial growth factor (VEGF), an important mediator for inflammation and angiogenesis, decreased in IL-17 knockout mice, showing the relationship between IL-17 and VEGF. Conclusions: This study established an LPS-induced rhinitis model dependent on IL-17, characterized by neutrophil infiltration and increased expression of IL-17. KCI Citation Count: 8
Purpose Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a rhinitis model using ovalbumin (OVA) and LPS in order to evaluate the role of interleukin (IL)-17 in the pathogenesis of an LPS-induced non-eosionophilic rhinitis model. Methods Mice were divided into 4 groups and each group consisted of 10 mice (negative control group, allergic rhinitis model group, 1-[mu]g LPS treatment group, and 10-[mu]g LPS treatment group). BALB/c mice were sensitized with OVA and 1 or 10 [mu]g of LPS, and challenged intranasally with OVA. Multiple parameters of rhinitis were also evaluated to establish the LPS-induced rhinitis model. IL-17 knockout mice were used to check if the LPS-induced rhinitis model were dependent on IL-17. Eosinophil and neutrophil infiltration, and mRNA and protein expression profiles of cytokine in nasal mucosa or spleen cell culture were evaluated using molecular, biochemical, histopathological, and immunohistological methods. Results In the LPS-induced rhinitis model, neutrophil infiltration increased in the nasal mucosa, and systemic and nasal IL-17 and interferon-gamma (IFN-[gamma]) levels also increased as compared with the OVA-induced allergic rhinitis model. These findings were LPS-dose-dependent. In IL-17 knockout mice, those phenotypes (neutrophil infiltration, IL-17, and IFN-[gamma]) were reversed, showing IL-17 dependency of LPS-induced rhinitis. The expression of vascular endothelial growth factor (VEGF), an important mediator for inflammation and angiogenesis, decreased in IL-17 knockout mice, showing the relationship between IL-17 and VEGF. Conclusions This study established an LPS-induced rhinitis model dependent on IL-17, characterized by neutrophil infiltration and increased expression of IL-17.
Author Kim, Ji-Hye
Kim, Eun Hee
Mo, Ji-Hun
Bae, Jun-Sang
AuthorAffiliation 2 Department of Premedical Course, Dankook University College of Medicine, Cheonan, Korea
1 Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea
AuthorAffiliation_xml – name: 1 Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea
– name: 2 Department of Premedical Course, Dankook University College of Medicine, Cheonan, Korea
Author_xml – sequence: 1
  givenname: Jun-Sang
  surname: Bae
  fullname: Bae, Jun-Sang
  organization: Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea., Department of Premedical Course, Dankook University College of Medicine, Cheonan, Korea
– sequence: 2
  givenname: Ji-Hye
  surname: Kim
  fullname: Kim, Ji-Hye
  organization: Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea
– sequence: 3
  givenname: Eun Hee
  surname: Kim
  fullname: Kim, Eun Hee
  organization: Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea
– sequence: 4
  givenname: Ji-Hun
  surname: Mo
  fullname: Mo, Ji-Hun
  organization: Department of Otorhinolaryngology, Dankook University College of Medicine, Cheonan, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28102062$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002202376$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqNkd1rFDEUxYNUbK39A3yRedSHGfMxuUlexFL8WFgRlvU5ZPPhxs5O1mS20P_eTLctKgjel3tDzvlx4DxHJ2MaPUIvCe56AvKtMTF3FBPRqY52BNQTdEaxoq1gwE4eb85P0UUpP3AdRvoe-mfolEqCKQZ6ht6vt75ZpcE3KTSLZUtEE8fGNMu4T_s03BZj7dbk6Hy7GN3BetestnGMUyzNl-T88AI9DWYo_uJ-n6NvHz-srz63y6-fFleXy9b2AFPbSyfMJvTEsxqDsQ0TQLEFLgPD1AQuDWNgnQne9MIFr8BQ4RSw-txwwc7RmyN3zEFf26iTiXf7e9LXWV-u1gtduQCcVO27o3Z_2Oy8s36cshn0Psedybd3zj9_xritnBvNKQAhM-D1PSCnnwdfJr2LxfphMKNPh6KJVEQKqdT_SIFwAVzIKn31e6zHPA9tVIE4CmxOpWQftI2TmWKaU8ZBE6zn6vVcvZ6r10pTXauvTvKX8wH-b88v4Ravug
CitedBy_id crossref_primary_10_1016_j_biopha_2018_07_093
crossref_primary_10_3892_etm_2022_11116
crossref_primary_10_1089_jir_2021_0183
crossref_primary_10_3389_fimmu_2017_01835
crossref_primary_10_3389_fmicb_2022_1002084
crossref_primary_10_1002_clt2_12047
crossref_primary_10_1051_bioconf_202411102023
crossref_primary_10_1186_s12950_024_00415_9
crossref_primary_10_1021_acsfoodscitech_3c00351
crossref_primary_10_4168_aair_2022_14_1_5
crossref_primary_10_1177_1945892421998143
crossref_primary_10_1089_jmf_2020_4750
crossref_primary_10_3892_etm_2019_7631
crossref_primary_10_1016_j_bjorl_2020_05_020
crossref_primary_10_1016_j_intimp_2018_02_006
crossref_primary_10_1016_j_intimp_2023_110730
crossref_primary_10_4049_immunohorizons_2400061
crossref_primary_10_1002_kjm2_12215
crossref_primary_10_1111_all_15384
crossref_primary_10_1177_1945892420936587
crossref_primary_10_1186_s12860_018_0152_5
crossref_primary_10_1016_j_ejphar_2020_173564
crossref_primary_10_21053_ceo_2019_02005
crossref_primary_10_1016_j_jhazmat_2024_135800
crossref_primary_10_1186_s12890_021_01798_8
crossref_primary_10_1016_j_intimp_2021_108279
crossref_primary_10_1038_s41598_020_80483_y
crossref_primary_10_1177_19458924231152683
crossref_primary_10_1016_j_fct_2024_114435
Cites_doi 10.1007/s10067-005-1081-1
10.1016/j.imlet.2004.01.014
10.1164/ajrccm.160.5.9806170
10.1016/j.lfs.2006.12.038
10.1177/194589240602000219
10.4168/aair.2011.3.3.199
10.1046/j.1365-2222.2001.01081.x
10.1046/j.1365-2222.2001.01129.x
10.1513/pats.200808-087RM
10.1093/cvr/cvq397
10.1034/j.1399-3003.2000.15e28.x
10.1038/nm1105
10.1371/journal.pone.0058892
10.1172/JCI21275
10.4049/jimmunol.0901566
10.1016/j.jaci.2006.01.039
10.1111/j.1348-0421.1986.tb03015.x
10.2332/allergolint.R-07-160
10.1186/1476-7961-9-3
10.1007/s10753-012-9475-0
10.4049/jimmunol.168.6.3017
10.4049/jimmunol.181.6.4089
ContentType Journal Article
Copyright Copyright © 2017 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2017
Copyright_xml – notice: Copyright © 2017 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2017
DBID AAYXX
CITATION
NPM
7X8
7T5
7U7
C1K
H94
5PM
ACYCR
DOI 10.4168/aair.2017.9.2.169
DatabaseName CrossRef
PubMed
MEDLINE - Academic
Immunology Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE - Academic
PubMed

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2092-7363
EndPage 176
ExternalDocumentID oai_kci_go_kr_ARTI_1336651
PMC5266111
28102062
10_4168_aair_2017_9_2_169
Genre Journal Article
GrantInformation_xml – fundername: ;
GroupedDBID ---
5-W
53G
8JR
8XY
9ZL
AAKDD
AAYXX
ACPRK
ADBBV
ADRAZ
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
C~G
DIK
DYU
E3Z
EF.
F5P
GX1
HYE
KQ8
M48
O5R
O5S
OK1
PGMZT
RPM
NPM
7X8
7T5
7U7
C1K
H94
5PM
ACYCR
ID FETCH-LOGICAL-c466t-48d7abf41e303133b37620c658f302af58a336cdafea47dfe96a27d963a47b573
IEDL.DBID M48
ISSN 2092-7355
IngestDate Sun Mar 09 07:54:47 EDT 2025
Thu Aug 21 18:22:02 EDT 2025
Thu Jul 10 18:33:26 EDT 2025
Fri Jul 11 08:35:06 EDT 2025
Thu Apr 03 07:06:30 EDT 2025
Fri Jul 04 01:06:56 EDT 2025
Thu Apr 24 23:03:17 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords interleukin-17
Rhinitis
lipopolysaccharide
vascular endothelial growth factor
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c466t-48d7abf41e303133b37620c658f302af58a336cdafea47dfe96a27d963a47b573
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-SER000002443.2017.9.2.008
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4168/aair.2017.9.2.169
PMID 28102062
PQID 1861576578
PQPubID 23479
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1336651
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5266111
proquest_miscellaneous_1891878991
proquest_miscellaneous_1861576578
pubmed_primary_28102062
crossref_citationtrail_10_4168_aair_2017_9_2_169
crossref_primary_10_4168_aair_2017_9_2_169
PublicationCentury 2000
PublicationDate 2017-03-01
PublicationDateYYYYMMDD 2017-03-01
PublicationDate_xml – month: 03
  year: 2017
  text: 2017-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Allergy, asthma & immunology research
PublicationTitleAlternate Allergy Asthma Immunol Res
PublicationYear 2017
Publisher The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
대한천식알레르기학회
Publisher_xml – name: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
– name: 대한천식알레르기학회
References Lavinskiene (10.4168/aair.2017.9.2.169_ref5) 2012; 35
Tamura (10.4168/aair.2017.9.2.169_ref16) 1986; 30
Tsunematsu (10.4168/aair.2017.9.2.169_ref17) 2007; 80
Lee (10.4168/aair.2017.9.2.169_ref8) 2004; 10
Hussain (10.4168/aair.2017.9.2.169_ref14) 2001; 31
Lindén (10.4168/aair.2017.9.2.169_ref7) 2000; 15
Kim (10.4168/aair.2017.9.2.169_ref21) 2009; 183
Numasaki (10.4168/aair.2017.9.2.169_ref10) 2004; 93
McKinley (10.4168/aair.2017.9.2.169_ref6) 2008; 181
Mo (10.4168/aair.2017.9.2.169_ref15) 2006; 20
Holgate (10.4168/aair.2017.9.2.169_ref3) 2006; 117
Saito (10.4168/aair.2017.9.2.169_ref12) 2002; 168
Albano (10.4168/aair.2017.9.2.169_ref18) 2013; 8
Hayashi (10.4168/aair.2017.9.2.169_ref20) 2004; 114
Mo (10.4168/aair.2017.9.2.169_ref9) 2011; 3
Kämpe (10.4168/aair.2017.9.2.169_ref4) 2011; 9
Fahy (10.4168/aair.2017.9.2.169_ref2) 2009; 6
Ryu (10.4168/aair.2017.9.2.169_ref11) 2006; 25
Jatakanon (10.4168/aair.2017.9.2.169_ref1) 1999; 160
Oboki (10.4168/aair.2017.9.2.169_ref19) 2008; 57
Hata (10.4168/aair.2017.9.2.169_ref22) 2011; 90
Hellings (10.4168/aair.2017.9.2.169_ref13) 2001; 31
15378055 - Nat Med. 2004 Oct;10(10):1095-103
19786548 - J Immunol. 2009 Oct 15;183(8):5113-20
21156823 - Cardiovasc Res. 2011 May 1;90(2):364-72
10853869 - Eur Respir J. 2000 May;15(5):973-7
16163444 - Clin Rheumatol. 2006 Feb;25(1):16-20
16522446 - J Allergy Clin Immunol. 2006 Mar;117(3):496-506; quiz 507
17300813 - Life Sci. 2007 Mar 20;80(15):1388-94
10556116 - Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1532-9
21738886 - Allergy Asthma Immunol Res. 2011 Jul;3(3):199-204
11422139 - Clin Exp Allergy. 2001 May;31(5):782-90
19387026 - Proc Am Thorac Soc. 2009 May 1;6(3):256-9
21255397 - Clin Mol Allergy. 2011 Jan 21;9(1):3
15134897 - Immunol Lett. 2004 Apr 30;93(1):39-43
18768865 - J Immunol. 2008 Sep 15;181(6):4089-97
3796321 - Microbiol Immunol. 1986;30(9):883-91
16686392 - Am J Rhinol. 2006 Mar-Apr;20(2):212-8
18427165 - Allergol Int. 2008 Jun;57(2):121-34
15254594 - J Clin Invest. 2004 Jul;114(2):270-9
11884474 - J Immunol. 2002 Mar 15;168(6):3017-23
11467996 - Clin Exp Allergy. 2001 Jul;31(7):1048-59
23573194 - PLoS One. 2013;8(4):e58892
22576978 - Inflammation. 2012 Aug;35(4):1600-9
References_xml – volume: 25
  start-page: 16
  year: 2006
  ident: 10.4168/aair.2017.9.2.169_ref11
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-005-1081-1
– volume: 93
  start-page: 39
  year: 2004
  ident: 10.4168/aair.2017.9.2.169_ref10
  publication-title: Immunol Lett
  doi: 10.1016/j.imlet.2004.01.014
– volume: 160
  start-page: 1532
  year: 1999
  ident: 10.4168/aair.2017.9.2.169_ref1
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.160.5.9806170
– volume: 80
  start-page: 1388
  year: 2007
  ident: 10.4168/aair.2017.9.2.169_ref17
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2006.12.038
– volume: 20
  start-page: 212
  year: 2006
  ident: 10.4168/aair.2017.9.2.169_ref15
  publication-title: Am J Rhinol
  doi: 10.1177/194589240602000219
– volume: 3
  start-page: 199
  year: 2011
  ident: 10.4168/aair.2017.9.2.169_ref9
  publication-title: Allergy Asthma Immunol Res
  doi: 10.4168/aair.2011.3.3.199
– volume: 31
  start-page: 782
  year: 2001
  ident: 10.4168/aair.2017.9.2.169_ref13
  publication-title: Clin Exp Allergy
  doi: 10.1046/j.1365-2222.2001.01081.x
– volume: 31
  start-page: 1048
  year: 2001
  ident: 10.4168/aair.2017.9.2.169_ref14
  publication-title: Clin Exp Allergy
  doi: 10.1046/j.1365-2222.2001.01129.x
– volume: 6
  start-page: 256
  year: 2009
  ident: 10.4168/aair.2017.9.2.169_ref2
  publication-title: Proc Am Thorac Soc
  doi: 10.1513/pats.200808-087RM
– volume: 90
  start-page: 364
  year: 2011
  ident: 10.4168/aair.2017.9.2.169_ref22
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvq397
– volume: 15
  start-page: 973
  year: 2000
  ident: 10.4168/aair.2017.9.2.169_ref7
  publication-title: Eur Respir J
  doi: 10.1034/j.1399-3003.2000.15e28.x
– volume: 10
  start-page: 1095
  year: 2004
  ident: 10.4168/aair.2017.9.2.169_ref8
  publication-title: Nat Med
  doi: 10.1038/nm1105
– volume: 8
  start-page: e58892
  year: 2013
  ident: 10.4168/aair.2017.9.2.169_ref18
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0058892
– volume: 114
  start-page: 270
  year: 2004
  ident: 10.4168/aair.2017.9.2.169_ref20
  publication-title: J Clin Invest
  doi: 10.1172/JCI21275
– volume: 183
  start-page: 5113
  year: 2009
  ident: 10.4168/aair.2017.9.2.169_ref21
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0901566
– volume: 117
  start-page: 496
  year: 2006
  ident: 10.4168/aair.2017.9.2.169_ref3
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2006.01.039
– volume: 30
  start-page: 883
  year: 1986
  ident: 10.4168/aair.2017.9.2.169_ref16
  publication-title: Microbiol Immunol
  doi: 10.1111/j.1348-0421.1986.tb03015.x
– volume: 57
  start-page: 121
  year: 2008
  ident: 10.4168/aair.2017.9.2.169_ref19
  publication-title: Allergol Int
  doi: 10.2332/allergolint.R-07-160
– volume: 9
  start-page: 3
  year: 2011
  ident: 10.4168/aair.2017.9.2.169_ref4
  publication-title: Clin Mol Allergy
  doi: 10.1186/1476-7961-9-3
– volume: 35
  start-page: 1600
  year: 2012
  ident: 10.4168/aair.2017.9.2.169_ref5
  publication-title: Inflammation
  doi: 10.1007/s10753-012-9475-0
– volume: 168
  start-page: 3017
  year: 2002
  ident: 10.4168/aair.2017.9.2.169_ref12
  publication-title: J Immunol
  doi: 10.4049/jimmunol.168.6.3017
– volume: 181
  start-page: 4089
  year: 2008
  ident: 10.4168/aair.2017.9.2.169_ref6
  publication-title: J Immunol
  doi: 10.4049/jimmunol.181.6.4089
– reference: 16522446 - J Allergy Clin Immunol. 2006 Mar;117(3):496-506; quiz 507
– reference: 10556116 - Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1532-9
– reference: 17300813 - Life Sci. 2007 Mar 20;80(15):1388-94
– reference: 11422139 - Clin Exp Allergy. 2001 May;31(5):782-90
– reference: 19387026 - Proc Am Thorac Soc. 2009 May 1;6(3):256-9
– reference: 15378055 - Nat Med. 2004 Oct;10(10):1095-103
– reference: 22576978 - Inflammation. 2012 Aug;35(4):1600-9
– reference: 18768865 - J Immunol. 2008 Sep 15;181(6):4089-97
– reference: 21156823 - Cardiovasc Res. 2011 May 1;90(2):364-72
– reference: 11467996 - Clin Exp Allergy. 2001 Jul;31(7):1048-59
– reference: 15134897 - Immunol Lett. 2004 Apr 30;93(1):39-43
– reference: 21738886 - Allergy Asthma Immunol Res. 2011 Jul;3(3):199-204
– reference: 16686392 - Am J Rhinol. 2006 Mar-Apr;20(2):212-8
– reference: 11884474 - J Immunol. 2002 Mar 15;168(6):3017-23
– reference: 10853869 - Eur Respir J. 2000 May;15(5):973-7
– reference: 3796321 - Microbiol Immunol. 1986;30(9):883-91
– reference: 19786548 - J Immunol. 2009 Oct 15;183(8):5113-20
– reference: 21255397 - Clin Mol Allergy. 2011 Jan 21;9(1):3
– reference: 23573194 - PLoS One. 2013;8(4):e58892
– reference: 15254594 - J Clin Invest. 2004 Jul;114(2):270-9
– reference: 18427165 - Allergol Int. 2008 Jun;57(2):121-34
– reference: 16163444 - Clin Rheumatol. 2006 Feb;25(1):16-20
SSID ssj0000314464
Score 2.240017
Snippet Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish a...
Purpose Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to establish...
Purpose: Lipopolysaccharide (LPS) is a cell wall component of Gram-negative bacteria and important for pro-inflammatory mediators. This study aimed to...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 169
SubjectTerms Original
내과학
Title The Role of IL-17 in a Lipopolysaccharide-Induced Rhinitis Model
URI https://www.ncbi.nlm.nih.gov/pubmed/28102062
https://www.proquest.com/docview/1861576578
https://www.proquest.com/docview/1891878991
https://pubmed.ncbi.nlm.nih.gov/PMC5266111
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002202376
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Allergy, 2017, Asthma & Immunology Research, 9(2), , pp.169-176
journalDatabaseRights – providerCode: PRVCAB
  databaseName: Nutrition and Food Sciences Database
  customDbUrl:
  eissn: 2092-7363
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000314464
  issn: 2092-7355
  databaseCode: DYU
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.cabidigitallibrary.org/product/zd
  providerName: CAB International
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2092-7363
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000314464
  issn: 2092-7355
  databaseCode: KQ8
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals - Free Access to All
  customDbUrl:
  eissn: 2092-7363
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000314464
  issn: 2092-7355
  databaseCode: DIK
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 2092-7363
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000314464
  issn: 2092-7355
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2092-7363
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000314464
  issn: 2092-7355
  databaseCode: 5-W
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2092-7363
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000314464
  issn: 2092-7355
  databaseCode: RPM
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2092-7363
  dateEnd: 20250430
  omitProxy: true
  ssIdentifier: ssj0000314464
  issn: 2092-7355
  databaseCode: M48
  dateStart: 20091001
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fa9swEBZtB2Mvo93PrGvRxtjDQJ4l2ZL9tI3S0o5mD2WB7klIstSaBjtNUlj_-93FTlhGKHsytmVzOp1033HSfYR8UFEWTkVAbmWILPMxYw5wAMtCjNpZbVONB5yHP9TpKPt-mV9ukWX2vFfgbGNoh3xSo-k4-X17_wUmPODXBOBE8dnaGit7cp2UiUi4Kj9ObhnySmH-tSfZ2CaPwFcJtPthHwAs1mqJ8RCmnkVagsDgfbvU5-Yfrzmv7WYaN-HSf7dX_uWvTnbJ0x5o0m-dZeyRrdA8I4-HfSr9OfkKBkIv2nGgbaRn54xrWjfU0vN6grwJ9zPr8URWXQWG9B4-VPTiusatRjOKBGrjF2R0cvzz6JT1dArMZ0rNWVZU2rqY8SCxYKN0sLaI1AMEiTIVNuaFlVL5ysZgM13FUCordAUzFG5druVLstO0TXhNKD50AdCCzAES5s5lXnJellVMhdNcDEi61JPxfa1xpLwYG4g5ULUGVWtQtaY0woBqB-TT6pNJV2jjocbvQfnmxtcGy2Pj9ao1N1MDQcCZgb4plfMBebccGwNzBhMhtgnt3czwAnCcVrBYPdSm5IWGaBT-86obz5VcogBYliropl4b6VUDFGr9TVNfL2p35wiIOH_zH7LtkyfY527D21uyM5_ehQNAQHN3CNj_1-hwYcp_AET7A2M
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Role+of+IL-17+in+a+Lipopolysaccharide-Induced+Rhinitis+Model&rft.jtitle=Allergy%2C+asthma+%26+immunology+research&rft.au=Bae%2C+Jun+Sang&rft.au=Kim%2C+Ji+Hye&rft.au=Kim%2C+Eun+Hee&rft.au=Mo%2C+Ji+Hun&rft.date=2017-03-01&rft.issn=2092-7355&rft.volume=9&rft.issue=2&rft.spage=169&rft_id=info:doi/10.4168%2Faair.2017.9.2.169&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2092-7355&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2092-7355&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2092-7355&client=summon